|
CCDC138 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.074800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.042400E-01 |
| Normal-vs-Stage2 |
9.019400E-01 |
| Normal-vs-Stage3 |
3.949000E-01 |
| Normal-vs-Stage4 |
7.451000E-01 |
| Stage1-vs-Stage2 |
5.145000E-01 |
| Stage1-vs-Stage3 |
7.085200E-01 |
| Stage1-vs-Stage4 |
4.685200E-01 |
| Stage2-vs-Stage3 |
4.410400E-01 |
| Stage2-vs-Stage4 |
8.508000E-01 |
| Stage3-vs-Stage4 |
3.845000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.744800E-01 |
| Normal-vs-AfricanAmerican |
2.295700E-03 |
| Normal-vs-Asian |
9.765000E-01 |
| Caucasian-vs-AfricanAmerican |
4.821700E-04 |
| Caucasian-vs-Asian |
9.062000E-01 |
| AfricanAmerican-vs-Asian |
1.140420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.548400E-01 |
| Normal-vs-Female |
9.919600E-01 |
| Male-vs-Female |
4.138600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.529800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.484800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.844200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.555200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.943600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.872400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.908800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.204800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.529000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.476400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.276800E-01 |
| Normal-vs-Grade 2 |
9.329000E-01 |
| Normal-vs-Grade 3 |
5.244800E-01 |
| Normal-vs-Grade 4 |
6.381400E-01 |
| Grade 1-vs-Grade 2 |
9.165000E-01 |
| Grade 1-vs-Grade 3 |
7.318800E-01 |
| Grade 1-vs-Grade 4 |
6.632600E-01 |
| Grade 2-vs-Grade 3 |
5.204200E-01 |
| Grade 2-vs-Grade 4 |
6.583200E-01 |
| Grade 3-vs-Grade 4 |
8.922600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.317800E-01 |
| Normal-vs-ccB subtype |
1.727450E-01 |
| ccA subtype-vs-ccB subtype |
5.242100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.056600E-01 |
| Normal-vs-N1 |
2.538200E-01 |
| N0-vs-N1 |
3.327600E-01 |
|
|
